What are the ASCO/IDSA guidelines for the monitoring of outpatient treatment of neutropenic cancer patients?

Updated: Sep 16, 2018
  • Author: Alexandre Chan, PharmD, MPH, FCCP, BCPS (AQ-ID), BCOP; more...
  • Print
Answer

Answer

The following additional measures are also recommended:

  • Frequent evaluation for at least 3 days in clinic or at home
  • Daily or frequent telephone contact to verify (by home thermometry) that fever resolves
  • Monitoring of ANC and platelet count for myeloid reconstitution
  • Frequent return visits to clinic

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!